Medicus Pharma Overview
- Year Founded
-
2008
- Status
-
Public
- Employees
-
16
- Stock Symbol
-
MDCX
- Investments
-
2
- Share Price
-
$1.14
- (As of Friday Closing)
Medicus Pharma General Information
Description
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.
Contact Information
Website
www.medicuspharma.comCorporate Office
- 100 King Street West
- Suite 3400
- Toronto, Ontario M5X 1A4
- Canada
Corporate Office
- 100 King Street West
- Suite 3400
- Toronto, Ontario M5X 1A4
- Canada
Medicus Pharma Timeline
Medicus Pharma Stock Performance
As of 20-Nov-2026, Medicus Pharma’s stock price is $1.14. Its current market cap is $3.16M with 2.79M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.14 | $1.16 | $1.06 - $114.00 | $3.16M | 2.79M | 115K | -$76.53 |
Medicus Pharma Financials Summary
As of 30-Sep-2026, Medicus Pharma has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 18,047 | 36,919 | 27,565 | |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (42,575) | (35,247) | (11,181) | (4,730) |
| Net Income | (44,026) | (35,444) | (11,156) | (5,315) |
| Total Assets | 14,537 | 10,061 | 5,647 | 1,893 |
| Total Debt | 21,391 | 5,477 | 322 | 0 |
Medicus Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Medicus Pharma Signals
Medicus Pharma Acquisitions (2)
Medicus Pharma’s most recent deal was a Merger/Acquisition with Antev for . The deal was made on 29-Aug-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Antev | 29-Aug-2025 | Merger/Acquisition | Drug Discovery | ||
| Interactive Capital Partners (Orleans) | 29-Sep-2023 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) |
Medicus Pharma ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Medicus Pharma Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Antev | London, United Kingdom | 2013 |
Medicus Pharma FAQs
-
When was Medicus Pharma founded?
Medicus Pharma was founded in 2008.
-
Where is Medicus Pharma headquartered?
Medicus Pharma is headquartered in Toronto, Canada.
-
What is the size of Medicus Pharma?
Medicus Pharma has 16 total employees.
-
What industry is Medicus Pharma in?
Medicus Pharma’s primary industry is Drug Discovery.
-
Is Medicus Pharma a private or public company?
Medicus Pharma is a Public company.
-
What is Medicus Pharma’s stock symbol?
The ticker symbol for Medicus Pharma is MDCX.
-
What is the current stock price of Medicus Pharma?
As of 20-Nov-2026 the stock price of Medicus Pharma is $1.14.
-
What is the current market cap of Medicus Pharma?
The current market capitalization of Medicus Pharma is $3.16M.
-
What is Medicus Pharma’s annual earnings per share (EPS)?
Medicus Pharma’s EPS for 12 months was -$76.53.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process